Healthcare Analyst Pachaiyappan, along with Dr. Wexner, System Chief for Colorectal Surgery, Georgetown University Hospital, the science and business case for D-Plex 100 (relevant companies MDT, JNJ, BDX, MMM, STE, PYPD, GEHC, INVA, HRTX, APLS, CNMD) on an Analyst/Industry conference call to be held on December 10 at 11 am. Webcast Link
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDT:
- Medtronic’s Strategic Advancements and Early FDA Approval of Hugo Boost Buy Rating
- Medtronic’s Strategic Moves and Market Position: Balancing Growth Prospects with Current Valuation
- Medtronic’s Cautious U.S. Market Entry with HUGO: Hold Rating Amid Uncertain Impact
- Medtronic announces clearance of Hugo RAS by FDA for urological procedures
- Medtronic begins U.S. commercial launch of MiniMed 780G system